Name: NUTX Income Statement - Nutex Health Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

NUTX - Nutex Health Inc.

USD | NASDAQ | Industrials

NUTX Income Statement - Nutex Health Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	216.5	151.7	267.8	244.0	211.8	257.6	78.8	76.1	67.5	69.7	62.7	58.9	56.3	53.7	28.4	58.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Revenues
Revenues	880.0	875.3	479.9	247.6	219.3	331.5	274.0	1.4	1.4	0.0	0.0	0.5	1.1	1.5	1.6	1.8	0.9
Cost of Revenue	-	-	-	-	-	14.6	0.9	0.8	0.5	0.0	0.0	0.0	0.5	0.5	0.8	0.8	0.4
Gross Profit	-	-	-	-	-	316.9	273.1	0.5	0.9	(0.0)	0.0	0.5	0.6	1.0	0.8	1.0	0.5
Operating Expenses
Research & Development	-	-	-	-	-	0.3	0.6	0.8	0.5	-	-	-	-	-	-
Operating Income
Operating Income	276.2	275.6	130.7	(31.8)	(406.6)	170.3	153.2	(6.9)	(0.8)	(5.7)	(0.4)	(0.5)	(0.7)	(0.7)
Non-Operating
Interest Income	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Tax & Net
Income Tax Expense	57.8	64.4	15.0	(5.1)	13.1	1.0	0.2	0.0	0.0	-	-	-	-	-	-
Per Share
EPS Basic	13.79	11.13	10.23	(10.39)	(100.36)	0.22	0.18	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	297.2	296.2	149.7	(14.2)	(393.5)	177.9	159.1	(6.7)	(0.8)	(5.7)	(0.4)	(0.5)	(0.7)	(0.7)	(1.6)	(0.8)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	81.3	30.9	130.4	33.7	80.7	114.3	9.7	5.3	1.5	(26.1)	(0.8)	(0.4)	(4.4)	(5.8)	(428.7)	(1.4)	29.2	72.3	74.5	27.6	(4.1)	151.7	1.8	0.6	(0.9)	(3.6)	(0.9)	(1.5)	(0.9)	0.4	(0.4)	(0.5)	(0.4)	(3.6)	(0.7)	(1.2)	(0.2)	(0.1)	(0.1)	(0.1)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-	-	0.0	-	-	-	0.0	-	-	-
Interest Expense	4.7	5.0	5.5	5.7	6.1	5.1	5.4	5.1	4.4	4.2	4.1	4.8	3.1	2.9	3.4	4.4	1.9	3.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(0.0)	(0.0)	(1.0)	(4.3)	(3.3)	(0.0)	(0.1)	0.6	0.2	(0.3)	0.1	0.1	(0.2)	(0.2)	0.6	1.4	(2.4)
Pre-Tax Income	76.6	25.9	123.9	23.7	71.2	108.7	(2.6)	3.9	(0.2)	(30.7)	(4.9)	(5.1)	(7.8)	(8.9)	(431.5)	(4.3)

Tax & Net
Income Tax Expense	13.8	9.3	27.1	7.6	20.4	9.2	4.6	0.9	0.4	(3.0)	(0.3)	(0.8)	(0.9)	1.8	(8.5)	19.7	0.2	0.0	0.5	0.5	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	62.8	16.6	96.8	16.1	50.8	99.5	(7.2)	3.0	(0.5)	(27.7)	(4.5)	(4.3)	(6.9)	(10.7)	(422.9)	(24.0)	24.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	62.8	16.6	96.8	16.1	50.8	99.5	(7.2)	3.0	(0.5)	(27.7)	(4.5)	(4.3)	(6.9)	(10.7)	(422.9)	(24.0)	24.8
Net Income Attributable To Parent	46.8	11.8	55.4	(17.7)	21.2	61.6	(8.8)	(0.4)	(0.4)	(31.6)	(5.5)	(3.5)	(5.1)	(14.8)	(412.2)	(19.3)
Less: Minority Interest	16.0	4.8	41.4	33.8	29.6	37.9	1.6	3.4	(0.2)	3.9	1.0	(0.8)	(1.8)	4.1	(10.7)	(4.7)	3.4
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	46.8	11.8	55.4	(17.7)	21.2	61.6	(8.8)	(0.4)	(0.4)	(31.6)	(5.5)	(3.5)	(5.1)	33.7	(422.5)

Per Share
EPS Basic	6.70	-	8.27	(2.95)	3.74	-	(1.72)	(0.07)	(0.08)	-	(1.25)	(0.79)	(0.12)	-	(0.62)	(0.03)	0.04	-	0.09	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	6.52	-	7.76	(2.95)	3.33	-	(1.72)	(0.07)	(0.08)	-	(1.25)	(0.79)	(0.12)	-	(0.62)	(0.03)	0.04	-
Shares Basic	7.0	-	6.7	6.0	5.7	-	5.1	5.0	4.8	-	4.4	4.4	43.4	-	649.6	646.4	592.8	-
Shares Diluted	7.2	-	7.2	6.0	6.5	-	5.1	5.0	4.8	-	4.4	656.6	43.4	-	654.8	646.4	-	-

Supplementary Data
EBITDA	86.8	36.1	135.4	38.9	85.8	119.6	14.6	9.8	5.6	(21.5)	3.9	3.8	(0.5)	(2.5)	(424.4)	1.8	31.6	75.9	76.3	29.8	(4.1)	-	-	-	(0.9)	-	-	-	(0.9)	-	-	-	(0.4)	-	-	-	(0.2)	-	-	-
EBIT	81.3	30.9	130.4	33.7	80.7	114.3	9.7	5.3	1.5	(26.1)	(0.8)	(0.4)	(4.4)	(5.8)	(428.7)	(1.4)	29.2	72.3	74.5

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.3	0.2	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	14.4	17.8	11.3	12.5	10.0	12.7	9.9	10.7	8.7	8.5	7.8	9.8	7.2	2.4	6.8	4.1	6.6
Depreciation & Amortization	5.5	5.2	5.0	5.2	5.1	5.3	5.0	4.5	4.2	4.7	4.7	4.2	4.0	3.3	4.3	3.1
Amortization of Intangibles	0.3	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	10.5	15.2	24.5	91.2	37.7	27.3	12.3	17.3	8.7	39.4	7.9	10.0	9.3	2.5	405.0	8.0